SYNGAP1 and schizophrenia: In humans, de novo loss-of-function mutations in SYNGAP1 are among the most common causes of non-syndromic sporadic intellectual disability (Hamdan et al., 2009) and may be associated with schizophrenia (Xu et al., 2012).